NUSAP1 and breast carcinoma: Intriguingly, through analysis of GSE22533 dataset which comprises fulvestrant treatment data, we found that NUSAP1 was markedly downregulated upon fulvestrant treatment in both breast cancer and liver cancer cell lines (Figure 9 F-G).